Beta-lactams and beta-lactamase-inhibitors in current- or potential-clinical practice: a comprehensive update (Q37514259)

20 August 2017

1 reference

title

Beta-lactams and beta-lactamase-inhibitors in current- or potential-clinical practice: a comprehensive update (English)

1 reference

20 August 2017

1 reference

M Shahid

1

1 reference

20 August 2017

F Sobia

2

1 reference

20 August 2017

A Singh

3

1 reference

20 August 2017

A Malik

4

1 reference

20 August 2017

H M Khan

5

1 reference

20 August 2017

D Jonas

6

1 reference

20 August 2017

P M Hawkey

7

1 reference

20 August 2017

language of work or name

English

0 references

publication date

1 January 2009

1 reference

Critical Reviews in Microbiology

20 August 2017

published in

1 reference

20 August 2017

volume

35

1 reference

20 August 2017

issue

2

1 reference

20 August 2017

page(s)

81-108

1 reference

Cephalosporins 1945-1986.

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

Ceftazidime-hydrolysing CTX-M-15 extended-spectrum beta-lactamase (ESBL) in Poland

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

Synthesis of penicillin: 6-aminopenicillanic acid in penicillin fermentations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

Antistaphylococcal activity of ceftobiprole, a new broad-spectrum cephalosporin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

In vitro activity of AVE1330A, an innovative broad-spectrum non-beta-lactam beta-lactamase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactamases in New York City

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

New beta-lactamases in gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

A functional classification scheme for beta-lactamases and its correlation with molecular structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

Kinetic interactions of tazobactam with beta-lactamases from all major structural classes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

Mobile genes coding for efflux-mediated antimicrobial resistance in Gram-positive and Gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

A semi-synthetic penicillinase inactivator

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

Molecular characterization of a beta-lactamase gene, blaGIM-1, encoding a new subclass of metallo-beta-lactamase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

In vitro activities of RWJ-54428 (MC-02,479) against multiresistant gram-positive bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

Activities of faropenem, an oral beta-lactam, against recent U.S. isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

Ertapenem: a review of its use in the management of bacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

Activities of ceftobiprole and other beta-lactams against Streptococcus pneumoniae clinical isolates from the United States with defined substitutions in penicillin-binding proteins PBP 1a, PBP 2b, and PBP 2x.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

Characterization of a chromosomally encoded extended-spectrum class A beta-lactamase from Kluyvera cryocrescens

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

Novel class 1 integron (InS21) carrying blaCTX-M-2 in Salmonella enterica serovar infantis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

IMP-12, a new plasmid-encoded metallo-beta-lactamase from a Pseudomonas putida clinical isolate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

Beta-Lactam antibiotics (1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

TEM- and SHV-derived extended-spectrum beta-lactamases: relationship between selection, structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

RWJ-54428 (MC-02,479), a new cephalosporin with high affinity for penicillin-binding proteins, including PBP 2a, and stability to staphylococcal beta-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

Activity of sulbactam in combination with ceftriaxone in vitro and in experimental endocarditis caused by Escherichia coli producing SHV-2-like beta-lactamase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

Kinetic studies on the inactivation of Escherichia coli RTEM β-lactamase by clavulanic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

Beta-lactamases and bacterial resistance to antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

In vitro activities of ertapenem (MK-0826) against clinical bacterial isolates from 11 North American medical centers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

In vitro activity of S-3578, a new broad-spectrum cephalosporin active against methicillin-resistant staphylococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

In vitro and in vivo activities of a novel cephalosporin, BMS-247243, against methicillin-resistant and -susceptible staphylococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

Serine beta-lactamases and penicillin-binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

VIM-1 Metallo-beta-lactamase-producing Klebsiella pneumoniae strains in Greek hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

AmpC beta-lactamases: what do we need to know for the future?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

In vitro activities of novel trans-3,5-disubstituted pyrrolidinylthio-1beta-methylcarbapenems with potent activities against methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

Molecular epidemiology of clinically significant antibiotic resistance genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

In vitro and in vivo properties of Ro 63-9141, a novel broad-spectrum cephalosporin with activity against methicillin-resistant staphylococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

Evolution and spread of SHV extended-spectrum beta-lactamases in gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

In vitro antianaerobic activity of ertapenem (MK-0826) compared to seven other compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

Beta-lactamases of Kluyvera ascorbata, probable progenitors of some plasmid-encoded CTX-M types

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

In vitro antimicrobial activity of T-91825, a novel anti-MRSA cephalosporin, and in vivo anti-MRSA activity of its prodrug, TAK-599.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

Amino acid substitutions in a variant of IMP-1 metallo-beta-lactamase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

More extended-spectrum beta-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

In vitro and in vivo activities of AM-112, a novel oxapenem.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

“Celbenin” - resistant Staphylococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

Aminoglycoside efflux in Pseudomonas aeruginosa: involvement of novel outer membrane proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

In vitro evaluation of ertapenem (MK-0826), a long-acting carbapenem, tested against selected resistant strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

In vitro evaluation of BAL9141, a novel parenteral cephalosporin active against oxacillin-resistant staphylococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

In vitro and in vivo antibacterial activities of CS-023 (RO4908463), a novel parenteral carbapenem

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

Carbapenem-resistant Klebsiella pnuemoniae in Singapore producing IMP-1 beta-lactamase and lacking an outer membrane protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

Comparative in vitro and in vivo activities of piperacillin combined with the beta-lactamase inhibitors tazobactam, clavulanic acid, and sulbactam

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

In vitro activities of ME1036 (CP5609), a novel parenteral carbapenem, against methicillin-resistant staphylococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

Structure of the SHV-1 beta-lactamase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

Inhibition of the SHV-1 beta-lactamase by sulfones: crystallographic observation of two reaction intermediates with tazobactam

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

In vitro activities of novel oxapenems, alone and in combination with ceftazidime, against gram-positive and gram-negative organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

Novel acquired metallo-beta-lactamase gene, bla(SIM-1), in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

Augmentin (amoxycillin and clavulanic acid) therapy in complicated infections due to beta-lactamase producing bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

Beta-lactamase-mediated resistance and opportunities for its control

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

The beta-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

Properties and potential of ertapenem

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

In vitro activities of ertapenem (MK-0826) against recent clinical bacteria collected in Europe and Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

The Aeromonas hydrophila cphA gene: molecular heterogeneity among class B metallo-beta-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

First isolation of bla(VIM-2) in Latin America: report from the SENTRY Antimicrobial Surveillance Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

In vitro and in vivo antibacterial activities of L-084, a novel oral carbapenem, against causative organisms of respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

Klebsiella pneumoniae isolate producing at least eight different beta-lactamases, including AmpC and KPC beta-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

Comparative stability of carbapenem and penem antibiotics to human recombinant dehydropeptidase-I

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

In vitro activity of a new carbapenem antibiotic, BO-2727, with potent antipseudomonal activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

Biochemical properties of a carbapenem-hydrolyzing beta-lactamase from Enterobacter cloacae and cloning of the gene into Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

Molecular characterization of an enterobacterial metallo beta-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

Antipneumococcal activity of ertapenem (MK-0826) compared to those of other agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

Extended-spectrum beta-lactamases: a clinical update

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

Chromosome-encoded Ambler class A beta-lactamase of Kluyvera georgiana, a probable progenitor of a subgroup of CTX-M extended-spectrum beta-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

GES-2, a class A beta-lactamase from Pseudomonas aeruginosa with increased hydrolysis of imipenem

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

First isolation of a carbapenem-hydrolyzing beta-lactamase in Pseudomonas aeruginosa in Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

SME-type carbapenem-hydrolyzing class A beta-lactamases from geographically diverse Serratia marcescens strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

The inhibition of beta-lactamases from gram-negative bacteria by clavulanic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

The beta-lactamases of gram-negative bacteria and their possible physiological role.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

Microbiological studies on a new broad-spectrum penicilin, "Penbritin".

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

Antimicrobial activities of Ceftaroline and ME1036 tested against clinical strains of community-acquired methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

Antimicrobial activity and spectrum of PPI-0903M (T-91825), a novel cephalosporin, tested against a worldwide collection of clinical strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

Spread of bla(VIM-1)-producing E. coli in a university hospital in Greece. Genetic analysis of the integron carrying the bla(VIM-1) metallo-beta-lactamase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

In vitro efficacy of ceftriaxone/sulbactam against Escherichia coli isolates producing CTX-M-15 extended-spectrum beta-lactamase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

Pharmacokinetics and disposition of CS-023 (RO4908463), a novel parenteral carbapenem, in animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

Activity of faropenem against middle ear fluid pathogens from children with acute otitis media in Costa Rica and Israel

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

Antimicrobial activity of SM-17466, a novel carbapenem antibiotic with potent activity against methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

CS-023 (R-115685), a novel carbapenem with enhanced in vitro activity against oxacillin-resistant staphylococci and Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

Beta-lactamase production in members of the family Enterobacteriaceae and resistance to beta-lactam-enzyme inhibitor combinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

ISCR elements: novel gene-capturing systems of the 21st century?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

Molecular and biochemical characterization of OXA-45, an extended-spectrum class 2d' beta-lactamase in Pseudomonas aeruginosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

blaVIM-7, an evolutionarily distinct metallo-beta-lactamase gene in a Pseudomonas aeruginosa isolate from the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

Penicillin-binding proteins and the antibacterial effectiveness of beta-lactam antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

Multiple-Antibiotic-Resistant Pathogenic Bacteria -- A Report on the Rockefeller University Workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

In vivo antibacterial activity of S-3578, a new broad-spectrum cephalosporin: methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa experimental infection models

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

In vitro and in vivo activities of novel 2-(thiazol-2-ylthio)-1beta-methylcarbapenems with potent activities against multiresistant gram-positive bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

Molecular characterization of SPM-1, a novel metallo-beta-lactamase isolated in Latin America: report from the SENTRY antimicrobial surveillance programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

Metallo-beta-lactamases: the quiet before the storm?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

The structural bases of antibiotic resistance in the clinically derived mutant beta-lactamases TEM-30, TEM-32, and TEM-34

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

Penicillins and cephalosporins are active site-directed acylating agents: evidence in support of the substrate analogue hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

In vitro activity of cefoperazone plus sulbactam compared with that of other antimicrobial agents against anaerobic bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

Meropenem. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

Metallo-beta-lactamases in clinical Pseudomonas isolates in Taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

Biochemical characterization of a beta-lactamase that hydrolyzes penems and carbapenems from two Serratia marcescens isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

Diffusion of beta-lactam antibiotics through the porin channels of Escherichia coli K-12

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

A new integron carrying VIM-2 metallo-beta-lactamase gene cassette in a Serratia marcescens isolate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

Bacterial Penicillin Amidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

Formation of 6-Aminopenicillanic Acid from Penicillin by Enzymatic Hydrolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408410902733979

10.1080/10408410902733979

21 January 2018

Identifiers

DOI

1 reference

release_w2j5qnrennflvh63v7ovxraunq

20 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/w2j5qnrennflvh63v7ovxraunq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference